[HTML][HTML] The mTOR–autophagy axis and the control of metabolism

N Deleyto-Seldas, A Efeyan - Frontiers in cell and developmental …, 2021 - frontiersin.org
The mechanistic target of rapamycin (mTOR), master regulator of cellular metabolism, exists
in two distinct complexes: mTOR complex 1 and mTOR complex 2 (mTORC1 and 2) …

Autophagy in the physiological endometrium and cancer

L Devis-Jauregui, N Eritja, ML Davis, X Matias-Guiu… - Autophagy, 2021 - Taylor & Francis
Autophagy is a highly conserved catabolic process and a major cellular pathway for the
degradation of long-lived proteins and cytoplasmic organelles. An increasing body of …

[HTML][HTML] SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway

W Liu, X Wang, Z Liu, Y Wang, B Yin, P Yu… - British journal of …, 2017 - nature.com
Background: Although inhibition of SGK1 has been shown to delay cancer progression, the
underlying mechanisms have not yet been elucidated. Methods: We investigated the cellular …

[HTML][HTML] JNK, p38, ERK, and SGK1 inhibitors in cancer

J Cicenas, E Zalyte, A Rimkus, D Dapkus, R Noreika… - Cancers, 2017 - mdpi.com
Mitogen-activated protein kinases (MAP kinases) are a family of kinases that regulates a
range of biological processes implicated in the response to growth factors like latelet …

[HTML][HTML] SGK1 in human cancer: emerging roles and mechanisms

Y Sang, P Kong, S Zhang, L Zhang, Y Cao… - Frontiers in …, 2021 - frontiersin.org
Serum and glucocorticoid-induced protein kinase 1 (SGK1) is a member of the “AGC”
subfamily of protein kinases, which shares structural and functional similarities with the AKT …

[HTML][HTML] SGK1, a critical regulator of immune modulation and fibrosis and a potential therapeutic target in chronic graft-versus-host disease

R Lu, Y Zhang, H Zhao, R Guo, Z Jiang… - Frontiers in …, 2022 - frontiersin.org
Patients with severe chronic graft-versus-host disease (cGVHD) always experience
debilitating tissue injury and have poorer quality of life and shorter survival time. The early …

[HTML][HTML] RANBP1 (RAN binding protein 1): the missing genetic piece in cancer pathophysiology and other complex diseases

S Audia, C Brescia, V Dattilo, L D'Antona, P Calvano… - Cancers, 2023 - mdpi.com
Simple Summary In just less than 30 years since the cloning of RANBP1 (RAN binding
protein 1), this review represents the first attempt for a comprehensive and analytical …

[HTML][HTML] SGK1 in cancer: Biomarker and drug target

J Cicenas, E Meskinyte-Kausiliene, V Jukna, A Rimkus… - Cancers, 2022 - mdpi.com
Serum-and glucocorticoid-regulated kinases (SGKs) are members of the AGC family of
serine/threonine kinases, consisting of three isoforms: SGK1, SGK2, and SGK3. SGK1 was …

The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star

R Zhu, G Yang, Z Cao, K Shen… - … in medical oncology, 2020 - journals.sagepub.com
Serum and glucocorticoid-inducible kinase 1 (SGK1) is an AGC kinase that has been
reported to be involved in a variety of physiological and pathological processes. Recent …

[HTML][HTML] Role of endometrial autophagy in physiological and pathophysiological processes

S Yang, H Wang, D Li, M Li - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
Endometrium is the mucosal lining of the uterus which expressed a cyclic process of
proliferation, secretion and scaling under the control of hormones secreted by the ovary, and …